Home » Healthcare » Pharmaceuticals » Foot And Mouth Disease (FMD) Vaccines Market

Foot And Mouth Disease (FMD) Vaccines Market By Vaccine Type (Conventional Vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Swine, Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 5648 | Report Format : PDF

Industry Outlook

The global foot and mouth disease (F.M.D.) vaccines market is expected to reach US$ 2,935.1 mn in 2026, with a compound annual growth rate (CAGR) of 8.1% from 2018 to 2026. F.M.D. is a highly contagious viral disease that can be fatal in cloven-hoofed animals such as domestic and wild bovids. Control and prevention of F.M.D. need vaccination, continuous monitoring, trade restrictions, and isolations, or the elimination of millions of animals to prevent the spread of the disease. The World Organization for Animal Health (O.I.E.) divides countries into three categories in terms of F.M.D.: F.M.D. present with or without vaccination, F.M.D. free without vaccination, and F.M.D. free with vaccination. Countries classified as FMD-free without vaccination have the highest exports of animal-derived components; therefore, these countries strive hard to maintain their current status by preventing the F.M.D.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

viruses. Favorable government initiatives to prevent and restrict F.M.D. outbreaks have boosted the demand for F.M.D. vaccines. The high prevalence of foot and mouth disease in developing countries in the Asia Pacific and Latin America is also contributing to the F.M.D. vaccine market’s steady growth. Asia Pacific held the largest share in the global F.M.D. vaccine market owing to a large number of cattle and dairy animals in developing countries such as India, Bangladesh, China, Hong Kong, and Pakistan, which are susceptible to F.M.D. endemics. The F.M.D. vaccine market is dominated by a large number of domestic players. Moreover, government subsidies and funding for vaccine production and consumption have restricted the entry of large pharmaceutical companies into the market.

Market Synopsis

The market will be driven by rising demand for oil-based vaccines.

In 2017, conventional vaccines held the largest share of the global F.M.D. vaccine market in terms of vaccine type. The rise in preventive vaccination programs in F.M.D. endemic-prone areas and developed countries such as the U.S., Canada, and the U.K. will continue to boost the market for conventional vaccines during the forecast period. Conventional vaccines are further segmented into aluminum hydroxide- and saponin-based vaccines and oil-based vaccines. Oil-based vaccines are anticipated to grow at the fastest rate during the forecast period from 2018 to 2026, owing to advantages associated with oil-based F.M.D. vaccines, such as the initiation of high titers and longer antibody responses resulting in better protection. Emergency vaccines are also expected to grow at a steady rate during the forecast period owing to the growing cases of F.M.D. in the developing region.

Asia Pacific will be the market leader for Foot and Mouth Disease Vaccines.

In 2017, Asia Pacific held the largest share in the global F.M.D. vaccines market, owing to the presence of developing nations with high headcounts of cattle, pigs, and sheep, which are susceptible to F.M.D. viruses. Agriculture and dairy industries are two of the most important industries in countries such as India, China, Bangladesh, and Pakistan; hence, regular vaccination drives are conducted by the government to prevent outbreaks of F.M.D. that would affect the dairy and agriculture industries. According to the O.I.E., FMD-related direct and indirect losses total approximately $5 billion globally. The impact of F.M.D. has led to successful campaigns of disease eradication in developed regions in North America and Europe. Because there have been few cases of F.M.D. in these regions, the F.M.D. vaccines market in North America and Europe will grow at a slower rate than in other regions.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The Foot and Mouth Disease Vaccines Market Report furnishes quantitative analysis along with its latest market trends. The market is segmented based on the vaccine type, animal type, and geography.

The market is studied in order to understand the current and future market trends in the foot-and-mouth disease vaccine market. The market is estimated by providing the compounded annual growth rate (CAGR) and a data forecast from 2018 to 2026. Strategic mergers, acquisitions, and collaborations among the key players for developing an innovative product pipeline are mentioned in the business strategy section. The key players currently engaged in the foot and mouth disease market are Merck Animal Health, Brilliant Bio Pharma Ltd., Agrovet Co., Indian Immunologics Limited, Merial S.A.S., Inova Biotecnologia, and Intervac (Pvt.) Ltd., among others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • How will the global foot and mouth disease vaccines market perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the foot-and-mouth disease vaccine market and valuable opportunities for key players?
  • Who are the leading players in the global foot and mouth disease vaccine market?
  • Which are the leading and fastest-growing regions in the global foot and mouth disease vaccine market?
  • Currently, what are the reimbursement scenario and regulatory structure for the foot-and-mouth disease vaccines?
  • What are the drivers and restraints governing the global foot-and-mouth disease vaccine market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global FMDV Market Portraiture
2.2. Global FMDV Market, by Vaccine Type, 2017 (US$ Mn)
2.3. Global FMDV Market, by Animal Type, 2017 (US$ Mn)
2.4. Global FMDV Market, by Geography, 2017 (US$ Mn)

Chapter 3. Foot and Mouth Disease Vaccines (FMDV) Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global FMDV Market, by Key Players, 2017

Chapter 4. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Vaccine Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Conventional Vaccines
4.2.1. Aluminum Hydroxide/Saponin based Vaccines
4.2.2. Oil-based Vaccine
4.3. Emergency Vaccines

Chapter 5. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Animal Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Cattle
5.3. Sheep & Goat
5.4. Swine
5.5. Others (Deer, Antelope, Gazelle)

Chapter 6. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America FMDV Market Analysis, 2016 – 2026
6.1.1. North America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.1.2. North America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
6.1.3. North America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe FMDV Market Analysis, 2016 – 2026
6.2.1. Europe FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.2.2. Europe FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
6.2.3. Europe FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific FMDV Market Analysis, 2016 – 2026
6.3.1. Asia Pacific FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America FMDV Market Analysis, 2016 – 2026
6.4.1. Latin America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.4.2. Latin America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
6.4.3. Latin America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa FMDV Market, 2016 – 2026
6.5.1. Middle East & Africa FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. India Immunological Ltd.
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Merck Animal Health
7.3. Brilliant Bio Pharma Ltd.
7.4. Agrovet Co.
7.5. Merial S.A.S
7.6. Inova Biotecnologia
7.7. Intervac (Pvt). Ltd.
7.8. China Animal Husbandry Co., Ltd.
7.9. Biogénesis-Bagó S.A.
7.10. Vetal Animal Health Products S.A.

List of Figures

FIG 1. Foot and Mouth Disease Vaccines (FMDV) Market: Research Methodology
FIG 2. FMDV Market Segmentation
FIG 3. Global FMDV Market, by Vaccine Type, 2017 (US$ Mn)
FIG 4. Global FMDV Market, by Animal Type, 2017 (US$ Mn)
FIG 5. Global FMDV Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global FMDV Market, by Key Players, 2017
FIG 8. Global Aluminum Hydroxide/Saponin based Vaccines Market, 2016-2026 (US$ Mn)
FIG 9. Global Oil-based Vaccines Market, 2016-2026(US$ Mn)
FIG 10. Global FMDV Market for Cattle, 2016-2026 (US$ Mn)
FIG 11. Global FMDV Market for Sheep & Goat, 2016-2026(US$ Mn)
FIG 12. Global FMDV Market for Swine, 2016-2026 (US$ Mn)
FIG 13. Global FMDV Market for Other Animals, 2016-2026 (US$ Mn)
FIG 14. U.S. FMDV Market, 2016-2026 (US$ Mn)
FIG 15. Canada FMDV Market, 2016-2026 (US$ Mn)
FIG 16. U.K. FMDV Market, 2016-2026 (US$ Mn)
FIG 17. Germany FMDV Market, 2016-2026 (US$ Mn)
FIG 18. Rest of Europe FMDV Market, 2016-2026 (US$ Mn)
FIG 19. China FMDV Market, 2016-2026 (US$ Mn)
FIG 20. Japan FMDV Market, 2016-2026 (US$ Mn)
FIG 21. India FMDV Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Asia Pacific FMDV Market, 2016-2026 (US$ Mn)
FIG 23. Brazil FMDV Market, 2016-2026 (US$ Mn)
FIG 24. Mexico FMDV Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America FMDV Market, 2016-2026 (US$ Mn)
FIG 26. GCC FMDV Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East & Africa FMDV Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Foot and Mouth Disease Vaccines (FMDV) Market Portraiture
TABLE 2 Global FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global FMDV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa FMDV Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 India Immunological Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Brilliant Bio Pharma Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Agrovet Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Merial S.A.S: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Inova Biotecnologia: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Intervac (Pvt). Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 China Animal Husbandry Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Biogénesis-Bagó S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetal Animal Health Products S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Foot And Mouth Disease (FMD) Vaccines Market?

The market for Foot And Mouth Disease (FMD) Vaccines Market is expected to reach US$ 2,935.1 Mn in 2026.

What is the Foot And Mouth Disease (FMD) Vaccines Market CAGR?

The Foot And Mouth Disease (FMD) Vaccines Market is expected to see significant CAGR growth over the coming years, at 8.1%.

What is the Forecast period considered for Foot And Mouth Disease (FMD) Vaccines Market?

The report is forecasted from 2018-2026.

What is the base year considered for Foot And Mouth Disease (FMD) Vaccines Market?

The base year of this report is 2017.

Who are the major players in this market?

Merck Animal Health, Brilliant Bio Pharma Ltd., Agrovet Co., Indian Immunologics Limited, Merial S.A.S., Inova Biotecnologia, and Intervac (Pvt.) Ltd. are some of the major players in the global market.

Prostate Cancer Market

Published:
Report ID: 36273

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN